Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-08

Clinical Trial Update: Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection [NA]

View source ↗

Summary

This terminated clinical trial assessed the efficacy and safety of Deoxyspergualin in renal transplant patients with chronic rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deoxyspergualin (deoxyspergualin)

Snippet

Sponsor: Nippon Kayaku Co., Ltd. | Conditions: Chronic Rejection | NA | Status: TERMINATED